Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

γδ T cells bring unconventional cancer-targeting to the clinic — again

A Publisher Correction to this article was published on 21 April 2020

This article has been updated

A growing number of companies seek to unleash these unusual T cells against cancer.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garber, K. γδ T cells bring unconventional cancer-targeting to the clinic — again. Nat Biotechnol 38, 389–391 (2020). https://doi.org/10.1038/s41587-020-0487-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-020-0487-2

This article is cited by